Hydroxystenozole
Introduction '''Hydroxystenozole''' (), also known as '''17α-methylandrost-4-eno3,2-''c''pyrazol-17β-ol''', is an orally active androgen/anabolic steroid (AAS) and a 17α-alkylated derivative of testosterone that was described in the literature in 1967 but was never marketed. It is closely related to stanozolol (17α-methyl-5α-androstano3,2-''c''pyrazol-17β-ol), differing from it only in hydrogenation (i.e., double bonds and their placement).
References